Therakind - Simple reusable intranasal device designed to actively deliver medicine in order to reduce anxiety in patients/care-givers and increase treatment adherence
Extending the applicability of Therakind’s previously developed single use intranasal dry powder parenteral administration system for use with a wider range of drugs. The newly extended role of the ...
- Funding £100,000
- Competition Medicines Adherence
- Competition Date Spring 2014
- Local AHSN Imperial College Health Partners AHSN
- Status In Development